Introduction
Since the introduction of DNA biochips in 1995 (1), the technology has been intensively applied in assays of genome-wide expression to seek information about possible functions of novel or poorly characterised genes (2) and for diagnostic purposes, as well (3) . Even though DNA microarray technology has shed light on many physiological functions of genes by determination of expression of gene clusters, there is quite often only a very low correlation between RNA and protein abundance detected in single-cell organisms (4) and in higher ones, including humans (5) . Since quantitative analysis of proteins is central to proteomics with a focus on design of novel drugs, diagnostics of diseases and their therapeutic applications, protein microarrays were successfully launched to address these issues (6) .
Analysis of finely tuned post-translational modifications (PTMs) of proteins is an additional challenge for current analytical technology. Glycosylation is a highly abundant form of PTM of proteins and it is estimated that 70%-80% of human proteins are glycosylated (7).
Importance of glycans can be further highlighted by the fact that 70% of all therapeutic proteins are glycosylated (8) . Glycan mediated recognition plays an important role in many different cell´s processes such as fertilisation, immune response, differentiation of cells, cellmatrix interaction, cell-cell adhesion etc. (9, 10) . Glycans present on the surface of cells are naturally involved in pathological processes including viral and bacterial infections, in neurological disorder and in tumour growth and metastasis (3, (11) (12) (13) (14) (15) (16) . Thus, better understanding of glycan mediated pathogenesis is essential in order to establish a "policy" to develop efficient routes for disease treatment with several recent studies as good examples e.g. "neutralisation" of various forms of viruses (17, 18) or more efficient vaccines against various diseases (19, 20) . A changed glycosylation on a protein backbone can be effectively applied in early stage diagnostics of several diseases, including different forms of cancer with known glycan-based biomarkers (21) (22) (23) . Moreover, many previously established and even commercially successful strategies used to treat diseases are currently being revisited in light of glycan recognition in order to lower side effects, enhance serum half-life or to decrease cellular toxicity (3, 24, 25) . Recently, the first glyco-engineered antibody was approved to the market, what was called by the authors "a triumph for glyco-engineering" (26) .
Glycomics focuses on revealing finely tuned reading mechanisms in the cell orchestra based on graded affinity, avidity and multivalency of glycans (i.e. sugar chains covalently attached to proteins and lipids) (27) . Glycans are information-rich molecules applicable in coding tools of the cell since they can form enormous number of possible unique sequences from basic building units (28). It is estimated that the size of the cellular glycome can be up to 500,000 glycan modified biomolecules (proteins and lipids) formed from 7,000 unique glycan sequences (29). Thus, it is not a surprise the glycome is sometimes referred to as the ''third alphabet'' in biology, after genetics and proteomics (30) . A huge glycan variation can explain human complexity in light of a paradoxically small genome. This glycan complexity together with similar physico-chemical properties of glycans is the main reason why the progress in the field of glycomics has been behind advances in genomics and proteomics (31) .
Traditional glycoprofiling protocols rely on glycan release from a biomolecule with a subsequent quantification by an array of techniques including capillary electrophoresis, liquid chromatography and mass spectrometry (32-34, 30, 35-37) . There is an alternative way for glycoprofiling by application of lectins, natural glycan recognising proteins (28, 38, 39) in combination with various transducing protocols (12, 40, 41) . The most powerful glycoprofiling tool relies on lectins arrayed on solid surfaces for direct analysis of glycoproteins, glycolipids, membranes and even glycans on the surface of intact cells (11, 42, 12, 43) . Even though lectin microarrays offer high throughput assay protocols with a minute consumption of samples and reagents, there are some drawbacks such as a need to fluorescently label the sample or the lectin, which negatively affects the performance of detection (11, 12) , relatively high detection limits and quite narrow working concentration ranges. Thus, the ideal detection platform should be based on protocols without a need to label a glycoprotein or a lectin, in a way similar to natural processes occurring within a cell (30) .
Lectins (lat. legere = to choose) are proteins able to recognise and reversibly bind to free or bound mono-and oligosaccharides (44) . They are not usually catalytically active, do not participate in the immune response of higher organisms and can be found in viruses, bacteria, fungi, plants and animals. They are therefore a relatively heterogeneous group of oligomeric proteins belonging to distinct families with similar sequences and are considered as natural glycocode decipherers (28). Lectins, unlike antibodies, have a low specificity and affinity with K d ranged from 10 -3 to 10 -7 M (30) and lectins with a new specificity cannot be raised in a way similar to antibodies.
In the following sections we will focus on ways how to improve glycan detection either by application of novel nanoscale-controlled patterning protocols, nanoengineered devices or by application of novel, recombinant lectins, lectin-like aptamers or lectin peptide aptamers. A final part of this book chapter will focus on a completely novel area in the glycomics -the idea of a glycocodon.
Perspectives of Novel Formats of Analysis Applicable in Glycomics
The use of nanotechnology, sophisticated nanoscale patterning protocols and advanced detection platforms can help to overcome the drawbacks of lectin microarray technology allowing it to work in a label-free mode of operation, with a high sensitivity, low detection limits, a wide concentration window and in some cases, real time analysis of a binding event is possible (9, 45-47, 30, 48-51) . These devices can differ in their mode of signal transduction compared to traditional methods and will be divided into three categories according to their mode of action. Various traditional analytical techniques based on lectins (i.e. surface plasmon resonance and quartz crystal microbalance) are covered by different chapters accompanied this one within this book and are not discussed here. !
Mechanical Platforms
Microcantilever biochips offer a novel approach for detection of a molecular binding based on a change in mass accumulated on the surface of a cantilever during biorecognition. It is a label-free technique allowing to monitor biospecific interaction in a real time, thus, affinity constants of the interaction can be acquired. When a biorecognition takes place, a particular
cantilever bends, what results in the shift of a laser beam angle, allowing for a direct detection of the binding event (Fig. 1A) .
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The device was prepared with variations in the density and composition of a glycan determinant immobilised via a thiol-gold surface chemistry on a cantilever surface. Namely galactose, trimannose and nonamannose were attached on the surface and probed with two different lectins -cyanovirin A and Concanavalin A (Con A). The later was successfully detected on a surface with optimal glycan composition down to a nanomolar range (52). The sensitivity is not impressive, but comparable to traditional surface plasmon resonance and quartz crystal microbalance lectin-based biosensors. The Seeberger´s group later extended this concept for analysis of several Escherichia coli strains on microcantilever biochips functionalised with different mannosides with a specific and reproducible detection with an amount of detectable E. coli cells over four orders of magnitude (53).
Electrical Platforms
Electrical/electrochemical detection is quite often utilised in combination with other techniques in the field of glycomics for some time (54) . Electrical platforms of detection of a biorecognition event are primarily based on changes in the electrical signals such as resistance, impedance, capacitance, conductance, potential, and current (55) . These analytical techniques are usually non-destructive, extremely sensitive, offering quite a wide concentration working range with a possibility to work in an array format of analysis (30).
Electrochemical impedance spectroscopy (EIS)
The most frequently used label-free electrochemical technique is EIS, which is based on an electric perturbation of a thin layer on the conductive surface by small alternating current amplitude with ability to provide characteristics of this interface utilisable in sensing. EIS results are typically transformed into a complex plane Nyquist plot vectors, which by application of an equivalent circuit can provide information about electron transfer resistance of a soluble redox probe in a direct way (Fig. 1B) . When a biorecognition took place, an electrode interface is modified and a subtle change in interfacial layer characteristics can be used for detection. EIS investigation is most frequently performed in the presence of a redox probe with detection of a change of resistance of the interface used for a signal generation.
EIS is extensively used as a non-destructive technique for reliable analysis of surface conditions and allows complex biorecognition events to be probed in a simple, sensitive and label-free manner and is being increasingly popular to develop electrochemical lectin-based biosensors for glycan determination (9, 30) . In our recent work we focused on the development of ultrasensitive impedimetric lectin biosensors with detection limits down to a single-molecule level based on controlled architecture at the nanoscale (59) (60) (61) . In the first study the biosensor was able to detect a glycoprotein in a concentration window spanning 7 orders of magnitude with a detection limit for the glycoprotein down to 0.3 fM, what was the lowest glycoprotein concentration detected (59) . In the following study an incorporation of gold nanoparticles offered even lower and unprecedented detection limit of 0.5 aM with quite a wide dynamic concentration range covered (61). In our last study the EIS-biosensors were constructed with three different lectins to be able to detect changes on immunoglobulins with progression of a rheumatoid arthritis in humans. The biosensor with improved antifouling properties offered a detection limit in the fM range and worked properly even with 1,000x diluted human plasma. The biosensor performance was directly compared to the state-of-the-art glycoprofiling tool based on fluorescent lectin microarrays with a detection limit in the nM level (60) . Moreover, a sandwich configuration offered a detection limit down to aM concentration (60). A detection limit down to fM range for analysis of alpha-fetoprotein (a biomarker for hepatocellular carcinoma) was recently observed on a device modified by arrays of single-walled carbon nanotubes and wheat-germ agglutinin with EIS as a transducing mechanism (62). !
Nanotube field effect transistor (NTFET) sensors
In NTFETs, semiconducting nanotubes or nanowires act as a channel between two metal electrodes (source and drain) while the two electrodes are held at a constant bias voltage using a so called gate electrode ( Fig. 2A) (49, 30) . When the device with an immobilised biorecognition element is exposed to the sample containing its binding partner, a change of the device conductivity can be applied for quantification of the analyte. The application of the FET devices in the field of glycobiology was pioneered by Star´s group (63, 64) . In the initial study carbon nanotubes were employed as a channel when glycoconjugate was immobilised on a surface of the device and an analyte lectin down to 2 nM concentration could be detected (63) . A forthcoming study confirmed that a carbon nanotube biosensor for detection of a lectin outperformed a device based on graphene (64) . However, semiconducting carbon nanotubes with a high purity are required to achieve better signal quality as a further research goal. Silicon nanowires were applied as a FET channel more effectively compared to carbon nanotubes and graphene, since a detection limit for a lectin down to 100 fg mL -1 (≈ fM level) was achieved (65) . Even though such a remarkable concentration of lectin with a glycan modified FET device was detected, analysis of glycoproteins on a lectin immobilised surface can be more problematic since the device is able to detect changes in a close proximity to the surface and a biorecognition lectin-glycoprotein can be too far from the surface to be detected. The solution, however, can lie in an application of ultra-diluted (100x or 1,000x) phosphate buffers allowing to detect biorecognition event at distances 7.5-23.9
nm from the surface, but for analysis of protein levels in serum, serum has to be desalted prior detection (66) .
!
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Another interesting approach applied in glycoassays was based on immobilisation of mannose inside a nanochannel and changes in the nanochannel conductance were after binding of Con A detected in a concentration window from 10 nM to 1,500 nM (67). The question how sensitive analysis of glycoproteins with lectins immobilised within a nanochannel can be, has to be still answered.
Optical Platforms
There are two different optical sensing mechanisms applied in label-free glycoanalysis.
The first is based on an intrinsic fluorescence of carbon nanotubes and the second one on a localised surface plasmon resonance detected on gold nanoislands. Both concepts have advantage since there is no necessity for an electronic interfacing, what is a problematic aspect of FET devices, and the nanoscale sensors require only a minute amount of sample for analysis.
Quenching of an intrinsic carbon nanotube fluorescence
This platform of detection employs fluorescent carbon nanotubes with a flexible NTAnickel tether attached, modulating fluorescent intensity of carbon nanotubes on one side and being applied as a coupling agent for His 6 -tagged lectins. When the glycoprotein interacts with an immobilised lectin, a nickel ion moves away from the carbon nanotube surface, partially restoring a quenched fluorescence of carbon nanotubes (Fig. 2B ). An increase in the fluorescence output can be applied not only for quantification of a glycoprotein level, but for monitoring of the interaction in a real time, providing kinetic and affinity constants, as well.
The absolute detection limit of the device for the glycoprotein was not that impressive (2 µg i.e. 670 nM), but authors believe the device has a room for improvement (i.e. by using high quality nanotube sensors) (47, 68) . In a recent study authors extended this initial study for glycoprofiling of different forms of IgGs (69).
!
A localised surface plasmon resonance
Noble metal nanostructures exhibiting a localised surface plasmon resonance, sensitive to changes in the refractive index near the nanostructures, can be integrated into a biosensor device. There is only one report on application of such a device in glycoassays (Fig. 3) . In 
Perspectives in Lectin Engineering
The glycan binding sites of lectins are usually a shallow groove or a pocket present at the protein surface, or at the interface of oligomers (7). Four main amino acids are part of an affinity site including asparagine, aspartic acid, glycine (arginine in Con A) and an aromatic residue for interaction with glycan via hydrogen bonds and hydrophobic interactions (71) .
Ionic interactions are especially involved in recognition of negatively charged glycans containing sialic acids. Lectin-monosaccharide binding is relatively weak, this is why several approaches were applied to enhance practical utility of lectins in glycoprofiling (7).
Recombinant DNA technology for producing lectins was traditionally applied to establish primary structure; to study genetics, evolution and biosynthesis; to elucidate the role of amino acids in recognition; to produce lectins with altered specificity and/or affinity; and to study their function in the organism of origin (72) . Novel trend is to apply this technology for producing lectins to be utilised for construction of various lectin-based biodevices.
Recombinant lectin technology can significantly reduce drawbacks of traditional lectin isolation such as a long processing time, often quite a low yield, batch-to-batch variation of the product quality depending on the source, with presence of various contaminants or different lectin isoforms (73, 11) . Moreover, recombinant technology offers to produce lectins either without any glycosylation, which can in many cases complicate glycoprofiling, by expression in prokaryotic hosts and to introduce various tags (His 6 -tag, glutathione transferase), which can be effectively utilised not only for one-step purification process, but more importantly for an oriented immobilisation of lectins on various surfaces (38) . Although lectin peptide aptamers have not been produced yet, it is a question of time, when such artificial glycan binding proteins emerge as an efficient tool in the area of glycobiology. It is estimated that another player in the area of glycoprofiling will make a substantial fingerprint lectin aptamers based on expanded genetic alphabet by introduction of modified nucleotides.
Other concepts based on modified lectins in glycoprofiling with added value are finally described.
Oriented Immobilisation of Recombinant Lectins
A controlled immobilisation of lectins on a diverse range of surfaces can have a detrimental effect on the sensitivity of assays, since lectins can be attached in a way a biorecognition site is directly exposed to the solution phase for an efficient biorecognition. As a result almost 100% of immobilised lectin molecules can have a proper orientation with an increased chance for catching its analyte (Fig. 4A) . Moreover a presence of a linker, which attaches tag to the protein backbone can significantly lower possible interaction of the protein with the surface, what can eventually lead to a denaturation of a protein (74) . allowing to quantify specificity of interaction. Moreover, it was found out that in the presence of monosaccharides during a lectin printing process better resolved spot morphology and lectin activity was achieved (75) . In a next study of the Mahal´s group, the effect of oriented immobilisation of lectins on the sensitivity of lectin microarray assays was quantified.
Oriented immobilisation of lectins offered a detection limit of approx. 12 ng mL −1 (ca. 640 pM protein) (76), a significantly lower level compared to a detection limit of 10 µg mL −1 achieved on a lectin microarray with a random immobilisation (33) . In a next study the group developed oriented immobilisation of recombinant lectins in a single step deposition of lectins together with a glutathione to an activated chip surface. Such an approach simplifies an overall immobilisation process because the surface does not need to be modified by glutathione prior lectin immobilisation (77).
Another group developed an oriented immobilisation of recombinant lectins produced with a fused Fc-fragment. Such a fragment has an affinity towards protein G (expressed in Streptococcus sp., much like a protein A) or a carbohydrate moiety of Fc fragment has an affinity for boronate derivatives (Fig. 4B) . Thus, a surface modified by a boronate derivatives or a protein G was effectively applied for oriented immobilisation of a recombinant lectin via a fused Fc fragment (78) . Although boronate immobilisation approach showed the highest sensitivity of detection, presence of boronate functionalities on the chip surface induced nonspecific interactions with glycoproteins and thus dextran blocking was introduced to minimise unwanted glycoprotein interactions. Additional drawback of such approach can be expected by introduction of Fc fragment having glycan entities, what can interact with glycan-binding proteins, which might be present in complex samples.
Perspectives for Peptide Lectin Aptamers
An alternative to production of mutated forms of lectins or glycosidases (7) for subsequent application in glycoprofiling in a future might be a preparation of novel forms of glycanrecognising proteins termed here as peptide lectin aptamers (PLA). Such proteins will be peptide aptamers with a lectin-like affinity to recognise various forms of glycans. A term peptide aptamer was coined by Colas et al. in 1996 (79) and is defined as a combinatorial protein molecule having a variable peptide sequence, with an affinity for a given target protein, displayed on an inert, constant scaffold protein (80) . Construction of various ! bioanalytical devices such as peptide lectin aptamer microarrays can benefit from such biorecognition elements since it would be possible to generate "army of terracotta soldiers" looking at the molecular level almost identical besides distinct "facial" feature of each entity provided by a unique peptide sequence. Even though lectin peptide aptamers have not been prepared yet, in our opinion, it is only a question of time, when such recognition elements will be prepared.
A beneficial feature of such a protein will be high solubility, a small, uniform size of a scaffold protein with an extended chemical and thermal stability and a possibility to express such proteins in prokaryotic expression systems, what is a cost-effective process (81) .
Moreover, when a small PLA will be immobilised on the surface of various bioanalytical devices, a higher density of biorecognition element can enhance sensitivity of detection, while suppressing non-specific interactions and lowering background signals (80) . Peptide aptamers are produced by protein engineering from high-complexity combinatorial libraries with appropriate isolation/selection methods (82, 80, 81) . Thus, a need to have knowledge of the protein structure and the mechanism behind binding is not necessary. There are however some requirements for the scaffold protein to posses such as lack of a biological activity and ability to accommodate a wide range of peptides without changing a 3-D structure (83).
Currently there are over 50 proteins described as potential affinity scaffolds, but only 
Perspectives for Novel Lectin-like Aptamers
The name aptamer coming from the Latin expression "aptus" (to fit) and the Greek word 
Other Novel Forms of Lectins
There are several very interesting strategies how to enhance analytical applicability of lectins by their simple modifications, which can dramatically influence the field of glycoprofiling in a future.
The first study focused on application of multimers of eight different lectins prepared by incubation of biotinylated lectins with streptavidin. A wheat germ agglutinin (WGA) multimers integrated into lectin microarrays showed 4-40 times better sensitivity in analysis of glycans in human plasma and much better performance in glycoprofiling of samples from people having pancreatic cancer compared to utilisation of WGA lectin monomer (98) . Authors of the study suggested that such lectin multimers with an enhanced affinity towards glycans can broaden the range of glycans, which can be detected. Moreover, according to authors lectin multimers might provide a fundamentally new biorecognition information not achievable by lectin monomers (98). The second study described attachment of a boronate functionality to two different lectins in order to enhance affinity 2 to 60-fold for a particular glycan binding (99) . Such modified lectins were tested in a whole cell lysate with an excellent specificity for analysis of 295 N-linked glycopeptides. These results revealed that application of boronate modified lectins can facilitate identification of glycans present on the surface of low-abundant glycoproteins (99) . The third study indicated that by preparation of a lectin mutant with artificially introduced cysteine into lectin Galanthus nivalis agglutinin it was possible to prepare lectin dimmers via a disulfide linkage between two lectin mutants (100).
Agglutination activity of a lectin dimmer increased 16-fold compared to a lectin monomer and interestingly a transformation monomer/dimmer can be redox-switchable by addition of mild oxidation or reducing agents (100). 
A Glycocodon Hypothesis
A codon (n 1 n 2 n 3 ) is a sequence of three DNA or RNA nucleotides that corresponds to a specific amino acid or stop signal during protein synthesis,!and the full set of codons is called a genetic code. The current state-of-the-art knowledge about the origin of the genetic code still remains as one of unsolved problems, and enormous number of theories can be divided to RNA world theories, protein world theories, co-evolution theories and stereochemical theories. Integration of these theories leads us to the conclusion that a system of four codons ("gnc", n= a -adenine, g -guanine, c -cytosine, u -uracil) and four amino acids (G -glycine,
A -alanine, V -valine, D -aspartic acid) could be the original genetic code (101) (102) (103) (104) (105) .
Research on a selection of particular RNA sequences with an amino acid binding activity, and a relation of those activities to the genetic code, have revealed an evidence that there is a highly robust connection between the genetic code and RNA-amino acid binding affinity (106) . It seems that the main part of the genetic code is influenced by a stereochemical prebiotic selection during the first polymerisation of G, A, V and D amino acids and g, c, u and a nucleic acids, however, only first two nucleotides of codons (n 1 n 2 ) are directly related to amino acid stereoselectivity (107) .
Recently, a similar evolution process was proposed for "the glycocode" (108) . The bioinformatics quantification of "GAVD-dipeptides" in monosaccharide specific proteins revealed that the amino acid triplets, the glycocodons (aa 1 aa 2 aa 3 ), can be deduced for each glycan letter (monosaccharide). The glycocodons are composed from one polar amino acid, interacting with sugar -OH groups, and one specific dipeptide, usually detecting C-C hydrophobic patch (see Glc, Gal and GlcNAc binding, Fig. 7a and 7c) . space and the glycocodons frequently overlap (Fig.7) .
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It should be emphasised that the glycocodons were theoretically deduced by a bioinformatics study and it will be necessary to perform a study in the laboratory to establish the strongest correlation between the monosaccharides and the glycocodons and to determine the shortest peptides for the recognition of the specific monosaccharide. However, the glycocodon theory represents a tool showing how the peptide lectin aptamers or novel DNA aptamers based on nucleotide derivatives should be organised and programmed. !
Conclusions
This 
